Plunkett Research Online: Celyad

CELYAD (CYAD) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Celyad Oncology is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno Oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T and C-Cure. The firm h.....


CELYAD

Ticker: CYAD
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 32 10394100
Fax: 32 10394141
Address: Rue Edouard Belin 2
Mont-Saint-Guibert, 1435 Belgium

Map
Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
Contacts Description

Celyad Oncology is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno Oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T and C-Cure. The firm h.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture